Patent · US Expired

Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells

US8343922B2 · kind B2 · utility

5Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 19, 2004
Grant dateJan 1, 2013
Priority date
Expiry dateMay 18, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for the treatment of bone diseases, bone fractures, bone injuries and other bone abnormalities involving the use of Dkk protein, a Wnt antagonist, a Wnt inhibitor, or any other related protein for the stimulation or enhancement of mineralization and for stimulating the renewal of cells. One Dkk protein, Dickkopf-2 (Dkk-2), acts to stimulate bone formation independently of Wnt proteins which may be inhibited and/or antagonized by Dkk-2. Dkk-2 displayed enhanced specific targeting ability and enhanced biological activity in stimulating or enhancing mineralization. Dkk-2 also played a role in the differentiation and self-renewal of hematopoietic stem cells and mesenchymal stem cells, particularly in osteoblastogenesis and osteoclastogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.